Discontinued Operations - Gain on the Sale of the VOWST Business (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Net assets transferred
Inventory						$ 29,647
Prepaid expenses and other current assets						1,075
Operating lease assets						19,376
Other non-current assets						39,167
Operating lease liabilities						$ (1,090)
Gain on sale, pre-tax		$ 146,707		$ 146,707	$ 0
VOWST Business [Member]
Consideration received
Upfront payment	[1]	79,788		79,788
Prepaid milestone		60,000		60,000
Deferred revenue from termination of 2016 License Agreement		95,364		95,364
Settlement of net collaboration payable at close		27,465		27,465
Premium on equity financing		1,484		1,484
Deferred income from termination of 2021 License Agreement		3,606		3,606
Accrued liabilities due to SPN - related party		(33,458)		(33,458)
Total fair value transferred for business		234,249		234,249
Net assets transferred
Inventory		63,442		63,442
Prepaid expenses and other current assets		2,219		2,219
Property and equipment, net		3,966		3,966
Operating lease assets		17,929		17,929
Other non-current assets		39,328		39,328
Accrued expenses and other current liabilities		(31,547)		(31,547)
Operating lease liabilities		(14,413)		(14,413)
Net assets transferred		80,924		80,924
Transaction costs		6,618		6,618
Gain on sale, pre-tax		146,707	$ 0	146,707	0
Income tax		$ 0	$ 0	0	$ 0
Gain on sale, net of tax				$ 146,707

[1] The upfront payment consists of $100,000, less $17,857 owed by the Company to an affiliate of SPN under the prior license agreement between the Company and the SPN affiliate, less approximately $2,355 in satisfaction of fees due under the Bacthera Manufacturing Agreement.